This study is currently not recruiting participants.

A SINGLE-CENTER RANDOMIZED 2-PERIOD CROSSOVER STUDY TO EXPLORE THE SAFETY PHARMACOKINETICS PHARMACODYNAMICS AND EFFICACY OF EOS789 IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND HYPERPHOSPHATEMIA ON HEMODIALYSIS

Investigation on the Safety and Effects of an Investigational Medication for Phosphorus Absorption

Not Recruiting
100 years or below
All
Phase N/A
1 Location

Brief description of study.

The purpose of this study is to test the safety of the study drug, EOS789, and to compare its effects, good or bad, with a placebo. The drug is designed to block the absorption of phosphorus in the intestine.

Detailed description of study

The purpose of this study is to test the safety of the study drug, EOS789, and to compare its effects, good or bad, with a placebo. The drug is designed to block the absorption of phosphorus in the intestine.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: hyperphosphatemia,chronic kidney disease
  • Age: 100 years or below
  • Gender: All

The purpose of this study is to test the safety of an investigational medication designed to block the absorption of phosphorus in the intestine. The study will compare the effects of the investigational medication with a placebo, which is an inactive substance that looks like the investigational medication but does not contain any medicine.

Participants will be randomly assigned to receive either the investigational medication or the placebo. The study will monitor participants for any effects, good or bad, to assess the safety and efficacy of the investigational medication.

  • Who can participate: Participants must be adults aged 18 and older with elevated phosphorus levels. Key eligibility factors include no history of severe gastrointestinal disorders and not currently participating in another clinical trial.
  • Study details: Participants will be randomly assigned to receive either the investigational medication or a placebo. The study will monitor participants for any effects to assess the safety and efficacy of the investigational medication.
Updated on 19 Feb 2024. Study ID: 1608100544

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team